Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma

BACKGROUND: As a novel treatment, programmed cell death protein 1 (PD-1) inhibitor appears to be less effective in tumors of lung adenocarcinoma patients with epidermal growth factor receptor (EGFR) mutation. Beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3) has reported to be associated with prog...

Full description

Saved in:
Bibliographic Details
Published in:Transl Lung Cancer Res
Main Authors: Leng, Xuefeng, Wei, Shiyou, Mei, Jiandong, Deng, Senyi, Yang, Zhenyu, Liu, Zheng, Guo, Chenglin, Deng, Yulan, Xia, Liang, Cheng, Jiahan, Zhao, Kejia, Gan, Fanyi, Li, Chuan, Merrell, Kenneth W., Molina, Julian R., Metro, Giulio, Liu, Lunxu
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2021
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947420/
https://ncbi.nlm.nih.gov/pubmed/33718036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-21-146
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items